masthead jeroen tas ces unveiled l

Oct 12, 2020

Jeroen Tas and Paul Stoffels discuss data and the learnings from COVID-19 at CES Unveiled

Estimated reading time: 1-3 minutes

Philips Chief Innovation & Strategy Officer Jeroen Tas, and Johnson & Johnson’s CSO Paul Stoffels, discuss learnings from COVID-19 and how they can be applied to future care

Artificial Intelligence, Data Analytics and Machine Learning have proven their value in the fight against COVID-19, but also have the potential to transform healthcare from a reactive, episodic system to a holistic, proactive one. However, lack of investment in secure interoperable data infrastructures is starving these technologies of the Big Data on which they depend.


During the Consumer Technology Association’s upcoming virtual CES Unveiled Conference on October 15, 2020, Jeroen Tas, Philips Chief Innovation & Strategy Officer, and Paul Stoffels, CSO at Johnson & Johnson, will give examples of how federated data networks and AI have provided valuable insights into real-world COVID-19 data, leading to the rapid deployment of evidence-based behavioral and clinical protocols with short feedback loops. They will then discuss how these technologies could be used to create future health systems that not only protect people when they get ill, but also empower them to take better care of their health throughout life. Jeroen and Paul will also touch on the power of AI and Machine Learning to accelerate medical research and run large-scale clinical trials in areas such as vaccine development.


Watch the event live at 2:50pm CET on October 15 on the CES Unveiled Conference: ‘Tech Solutions for Global Challenges’ platform (registration required).

Event information

Speaker information

  • Name speaker: Jeroen Tas
  • Role: Session speaker

Share on social media

  • Link copied



Joost Maltha

Joost Maltha

Philips Global Press Office

Tel: +31 6 10 55 8116

You are about to visit a Philips global content page


Related news

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.